pefloxacin has been researched along with Schnitzler Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dimopopoulos, MA; Gavriatopoulopu, M; Kastritis, E; Katoulis, A; Panayiotides, I; Terpos, E | 1 |
| Arnulf, B; Asli, B; Bienvenu, B; Brouet, JC; Cordoliani, F; Fermand, JP; Malphettes, M; Rybojad, M; Uzunhan, Y | 1 |
2 other study(ies) available for pefloxacin and Schnitzler Syndrome
| Article | Year |
|---|---|
Schnitzler's syndrome: increased levels of bone formation and angiogenesis factors are reduced after successful pefloxacin treatment.
Topics: Angiogenesis Inducing Agents; Anti-Infective Agents; Humans; Male; Middle Aged; Osteogenesis; Pefloxacin; Schnitzler Syndrome | 2008 |
Chronic urticaria and monoclonal IgM gammopathy (Schnitzler syndrome): report of 11 cases treated with pefloxacin.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Cohort Studies; Drug Therapy, Combination; Glucocorticoids; Humans; Middle Aged; Pefloxacin; Retrospective Studies; Schnitzler Syndrome; Treatment Outcome | 2007 |